Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences Total Liabilities (Quarterly) : 45.56M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 45.56M |
| June 30, 2026 | 1.843M |
| March 31, 2026 | 1.714M |
| December 31, 2025 | 0.90M |
| September 30, 2025 | 0.877M |
| June 30, 2025 | 0.80M |
| March 31, 2025 | 1.067M |
| December 31, 2024 | 0.725M |
| September 30, 2024 | 0.70M |
| June 30, 2024 | 1.282M |
| March 31, 2024 | 1.441M |
| December 31, 2023 | 2.086M |
| September 30, 2023 | 2.341M |
| June 30, 2023 | 4.947M |
| March 31, 2023 | 7.531M |
| December 31, 2022 | 7.627M |
| September 30, 2022 | 8.529M |
| June 30, 2022 | 9.852M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.491M |
| December 31, 2021 | 11.08M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 10.51M |
| March 31, 2021 | 51.53M |
| December 31, 2020 | 55.88M |
| September 30, 2020 | 56.05M |
| June 30, 2020 | 61.94M |
| March 31, 2020 | 58.49M |
| December 31, 2019 | 88.75M |
| September 30, 2019 | 90.51M |
| June 30, 2019 | 94.31M |
| March 31, 2019 | 17.52M |
| December 31, 2018 | 17.85M |
| September 30, 2018 | 14.88M |
| June 30, 2018 | 14.33M |
| March 31, 2018 | |
| December 31, 2017 | 14.04M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Q32 Bio, Inc. | 9.531M |
| IRulya Therapeutics, Inc. | -- |
| Climb Bio, Inc. | 8.511M |
| PepGen Inc. | 24.71M |
| Bridgebio Oncology Therapeutics, Inc. | 52.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 462.08M |
| Shareholders Equity (Quarterly) | 416.53M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 10.42 |
| Net Debt Paydown Yield | -0.02% |